Biomarker analyses of Asian women with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC) receiving ribociclib (RIB) plus endocrine therapy (ET)

被引：0

作者：

Yap, Y. S. ^{[1
]}

Masuda, N. ^{[2
]}

Ito, Y. ^{[3
]}

Ishikawa, T. ^{[4
]}

Kim, S. J. ^{[5
]}

Aruga, T. ^{[6
]}

Toyama, T. ^{[7
]}

Saeki, T. ^{[8
]}

Yamanaka, T. ^{[9
]}

Saito, M. ^{[10
]}

Watanabe, J. ^{[11
]}

Takahashi, M. ^{[12
]}

Nakamura, S. ^{[13
]}

Inoue, K. ^{[14
]}

Suarez-Vizcarra, J. ^{[15
]}

He, W. ^{[15
]}

Solovieff, N. ^{[16
]}

Su, F. ^{[15
]}

Chiu, J. ^{[17
]}

机构：

[1] Natl Canc Ctr, Med Oncol, Singapore, Singapore

[2] Osaka Natl Hosp, Med Oncol, Osaka, Japan

[3] Japanese Fdn Canc Res, Canc Inst Hosp, Med Oncol, Tokyo, Japan

[4] Tokyo Med Univ Hosp, Med Oncol, Tokyo, Japan

[5] Osaka Univ Hosp, Med Oncol, Osaka, Japan

[6] Tokyo Komagome Hosp, Med Oncol, Tokyo, Japan

[7] Nagoya City Univ, Grad Sch Med Sci, Med Oncol, Nagoya, Aichi, Japan

[8] Saitama Med Univ, Med Oncol, Int Med Ctr, Saitama, Japan

[9] Kanagawa Canc Ctr, Med Oncol, Yokohama, Kanagawa, Japan

[10] Juntendo Univ Hosp, Med Oncol, Tokyo, Japan

[11] Shizuoka Canc Ctr, Med Oncol, Nagaizumi, Shizuoka, Japan

[12] Hokkaido Canc Ctr, Natl Hosp Org, Med Oncol, Sapporo, Hokkaido, Japan

[13] Showa Univ Hosp, Breast Ctr, Tokyo, Japan

[14] Saitama Canc Ctr, Med Oncol, Saitama, Japan

[15] Novartis Pharmaceut, Novartis Oncol, E Hanover, NJ USA

[16] Novartis Inst BioMed Res, Biomarkers & Diagnost Biometr, Cambridge, MA USA

[17] Queen Mary Hosp, Med Oncol, Hong Kong, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

10.1093/annonc/mdy428

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

400

引用

页码：13 / +

页数：2

共 50 条

[21] Tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) with ribociclib (RIB) in premenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): MONALEESA-7 subgroup analysis [J].

Bardia, A. ;

Campos-Gomez, S. ;

Hurvitz, S. A. ;

Lu, Y-S. ;

Im, S-A. ;

Franke, F. ;

Chow, L. ;

Wheatley-Price, P. ;

Melo Cruz, F. ;

Alam, J. ;

Kong, O. ;

Diaz-Padilla, I. ;

Miller, M. ;

Tripathy, D. .

ANNALS OF ONCOLOGY, 2018, 29 :106-+

[22] Pooled efficacy analysis of first-line ribociclib (RIB) plus endocrine therapy (ET) in HR+/HER2: Advanced breast cancer (ABC) [J].

Tripathy, D. ;

Hortobagyi, G. N. ;

Chan, A. ;

Im, S-A. ;

Chia, S. ;

Yardley, D. ;

Esteva, F. J. ;

Hurvitz, S. A. ;

Ridolfi, A. ;

Slamon, D. .

ANNALS OF ONCOLOGY, 2019, 30 :49-+

[23] Endocrine therapy resistance (ETR) in hormone receptor-positive, HER2-negative metastatic breast cancer (HR+, HER2-mBC): Prevalence, biomarker characteristics, and outcomes. [J].

Jeselsohn, Rinath ;

Chen, Lu ;

Chaudhary, Nayan ;

Martinalbo, Jorge ;

Fasching, Peter A. ;

Hafner, Marc ;

Luhn, Patricia ;

Montero, Alberto J. ;

Perez-Moreno, Pablo Diego ;

Wander, Seth Andrew ;

Kalinsky, Kevin .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

[24] Ribociclib (RIB) plus non-steroidal aromatase inhibitor (NSAI) plus goserelin in premenopausal Asian women with hormone-receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): Results from the randomized phase III MONALEESA-7 study [J].

Im, S-A. ;

Sohn, J. ;

Tripathy, D. ;

Chow, L. ;

Lee, K. S. ;

Jung, K. H. ;

Babu, G. ;

Im, Y-H. ;

El Saghir, N. ;

Liu, M-C. ;

Diaz-Padilla, I. ;

Alam, J. ;

Kong, O. ;

Miller, M. ;

Lu, Y-S. .

ANNALS OF ONCOLOGY, 2018, 29

[25] HEALTH OUTCOME GAINS AND COSTS OFFSET ASSOCIATED WITH EVEROLIMUS FOR THE TREATMENT OF HORMONE-RECEPTOR-POSITIVE (HR+) HER2-NEGATIVE (HER2-) ADVANCED BREAST CANCER (ABC) [J].

Taylor, M. ;

Lewis, L. ;

Vieira, J. ;

Ricci, J. F. ;

Chandiwana, D. ;

Saletan, S. ;

Sahmoud, T. .

VALUE IN HEALTH, 2012, 15 (07) :A427-A427

[26] Ribociclib (RIB) plus tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) in premenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC) who received prior chemotherapy (CT): MONALEESA-7 subgroup analysis [J].

Hurvitz, Sara A. ;

Wheatley-Price, Paul ;

Tripathy, Debu ;

Lu, Yen-Shen ;

Chow, Louis ;

Bachelot, Thomas Denis ;

Hegg, Roberto ;

Chia, Stephen K. L. ;

Yardley, Denise A. ;

Kong, Oliver ;

Alam, Jahangir ;

Diaz-Padilla, Ivan ;

Baeck, Johan ;

Bardia, Aditya .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

[27] ALISertib in combination with endocrine therapy in patients with hormone receptor-positive (HR+), HER2-negative (HER2-) recurrent or metastatic breast cancer: The phase 2 ALISCA-Breast1 study. [J].

Advani, Pooja Prem ;

Braga, Sofia A. D. S. ;

Brufsky, Adam ;

Giridhar, Karthik ;

Mayer, Erica L. ;

McCann, Kelly Elizabeth ;

O'Regan, Ruth ;

Saura Manich, Cristina ;

Wander, Seth Andrew ;

Bischof, Georg Friedrich ;

Lowenthal, Beth Hillary ;

Bebchuk, Judith D. ;

Eli, Lisa DeFazio ;

Barnett, Brian ;

O'Shaughnessy, Joyce ;

Haddad, Tufia C. .

JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (16_SUPPL) :TPS1125-TPS1125

[28] Ribociclib plus fulvestrant in postmenopausal women with HR+, HER2-advanced breast cancer (ABC) [J].

Tolaney, S. M. ;

Forero-Torres, A. ;

Boni, V. ;

Bachelot, T. ;

Lu, Y-S ;

Maur, M. ;

Fasolo, A. ;

Motta, M. ;

Pan, C. ;

Dobson, J. ;

Hewes, B. ;

Lee, S. Chin .

CANCER RESEARCH, 2017, 77

[29] Ribociclib (RIB) plus tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) in premenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): MONALEESA-7 patient-reported outcomes (PROs) [J].

Harbeck, N. ;

Villanueva, R. ;

Franke, F. ;

Babu, G. ;

Wheatley-Price, P. ;

Im, Y-H. ;

Altundag, K. ;

Lanoue, B. ;

Alam, J. ;

Chandiwana, D. ;

Colleoni, M. .

ANNALS OF ONCOLOGY, 2018, 29

[30] MCM2 expression in locally advanced hormone receptor-positive HER2 negative (HR+/HER2-) early breast cancer receiving neoadjuvant chemotherapy. [J].

Susiriwatananont, Thiti ;

Iampenkhae, Kroongpong ;

Chumsri, Saranya ;

Parinyanitikul, Napa .

JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (16_SUPPL) :e12532-e12532

← 1 2 3 4 5 →